Scorpion Therapeutics key facts
as of Oct 2026- It has raised $150.0M across 3 recorded rounds; the latest was Later Stage VC (Series C) ($150.0M) in Jul 2024.
- 1 institutional filer reports fund marks on Scorpion Therapeutics across 15 filings.
- Scorpion Therapeutics has filed 3 Form Ds with the SEC since 2020, most recently Jul 2024 ($125.7M sold to 38 investors).
- ·Watch Scorpion Therapeutics: the Monday email on marks, rounds and moves
Institutional fund marks on Scorpion Therapeutics
1 filers · latest May 20261 SEC-registered fund reported 15 fair-value marks on Scorpion Therapeutics between May 2025 and May 2026. Filer-level marks and implied $/share are available to Pro members.
Membership and data by Private Market View
Scorpion Therapeutics funding rounds
3 roundsHow much has Scorpion Therapeutics raised?
Scorpion Therapeutics has raised $150 million across 3 recorded rounds since 2020. The largest was a $24.7 million early-stage round in Apr 2020; the most recent was a $150 million Series C in Jul 2024.
Scorpion Therapeutics has filed 3 Form Ds with the SEC since 2020, most recently in Jul 2024 ($126 million sold to 38 investors).
Institutional holders and vehicles
1 SEC-registered fund reported 15 fair-value marks on Scorpion Therapeutics between May 2025 and May 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
About Scorpion Therapeutics
- Industry
- Drug Discovery
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.